




Searching News Database: Proteostasis Therapeutics
HSMN NewsFeed - 30 Nov 2022
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
HSMN NewsFeed - 3 Dec 2021
Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer
Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer
HSMN NewsFeed - 24 Aug 2020
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
HSMN NewsFeed - 6 Feb 2019
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
HSMN NewsFeed - 17 Dec 2018
Proteostasis Therapeutics Announces Global License Agreement with Genentech
Proteostasis Therapeutics Announces Global License Agreement with Genentech
HSMN NewsFeed - 30 Jun 2014
Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer
Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer